Cancer Hospital Chinese Academy Of Medical Science, Shenzhen Center

This early study is testing a personalized mRNA vaccine called RH125 for people with advanced solid tumors who have run out of standard treatment options. Researchers will give the vaccine alone or combined with a PD-1 blocker drug to 36 patients to check if it's safe and to see …